University of Ioannina
Αποτελεσματικότητα και ασφάλεια της αζαθειοπρίνης σε ασθενείς με ιδιοπαθή φλεγμονώδη νόσο των εντέρων στη Βορειοδυτική Ελλάδα
Abstract
dc:descriptionIntroduction: Azathioprine is a chemical analogue of normal purines and is mainly used for its immunosuppressive effect. Despite the development of new agents for the treatment of inflammatory bowel disease, azathioprine (AZA) is widely used as monotherapy or combination therapy to induce and maintaining remission in both Crohn's disease and ulcerative colitis. The aim of this study was to investigate both the prevalence of malignancy development in IBD patients receiving AZA and the long-term safety of AZA and the management of adverse events.Methodology: Data were retrospectively extracted from the patient records of the Gastroenterology Department of the University Hospital of Ioannina from 1987 to 2020Results: The study included 222 patients with IBD treated with AZA, under regular follow-up intervals. 65.6% of IBD patients (146/222) had Crohn's disease and 34.4% had Ulcerative Colitis (76/222). The median duration of AZA administration was 51 months (range: 0-135 months). The most common AZA dose was 100 mg/day (range: 50–200 mg). The most common adverse events were gastrointestinal symptoms (8.6%, 18/222), leukopenia (2.7%, 6/222), hepatotoxicity (5.4%, 12/222) and pancreatitis (1.8%, 4/222). Two patients were diagnosed with basal cell carcinoma, while no hematologic malignancy was detected. Infections were recorded in 19 patients (8.6%) of which 6 required hospitalization.Conclusions: According to this retrospective observational study, approximately one-third of IBD patients treated with AZA experienced clinically significant adverse events during follow-up. Withdrawal or dose reduction of azathioprine was required in 47 (21%) patients.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kourtis, Georgios
- Κούρτης, Γεώργιος
Subjects
dc:subject × 18- Αζαθειοπρίνη
- Ασφάλεια
- Θειοπουρίνη
- Φλεγμονώδης νόσος του εντέρου
- Ελκώδης κολίτιδα
- Νόσος του Crohn
- Azathioprine
- Security
- Thiopurine
- Inflammatory bowel disease
- Ulcerative colitis
- Crohn's disease
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Γαστροεντερολογία
- Clinical Medicine
- Medical and Health Sciences
- Gastroenterology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52628